Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H.
Hulstaert F, et al. Among authors: pottel h.
Neurology. 1999 May 12;52(8):1555-62. doi: 10.1212/wnl.52.8.1555.
Neurology. 1999.
PMID: 10331678